CapsoVision (CV) Net Income towards Common Stockholders (2024 - 2025)

CapsoVision (CV) reported Net Income towards Common Stockholders of -$7.4 million for Q4 2025, down 59.39% on a YoY basis from -$18.2 million in Q4 2024, and up 6.65% sequentially from -$7.9 million in Q3 2025.

CapsoVision (CV) Net Income towards Common Stockholders (2024 - 2025) Analysis & Trends

CapsoVision (CV) has 2 years of Net Income towards Common Stockholders data on file, last reported at -$7.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Net Income towards Common Stockholders fell 59.39% year-over-year to -$7.4 million; the trailing twelve-month figure through Dec 2025 stood at -$24.6 million (changed N/A YoY), and the FY2025 full-year result was -$25.3 million, down 27.22% from the prior year.
  • Net Income towards Common Stockholders grew to -$7.4 million in Q4 2025, from -$7.9 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$4.6 million in Q2 2025 to a low of -$7.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.44 Bn 175.14 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.87 Bn 125.99 Bn 3.81 Bn 745.00 Mn
3 Medtronic 108.10 Bn 98.88 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.99 Bn 66.53 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.22 Bn 44.55 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.15 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 28.02 Bn 25.74 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 27.01 Bn 26.43 Bn - -
9 Koninklijke Philips 23.74 Bn 20.62 Bn 2.07 Bn 176.78 Mn
10 CapsoVision 163.05 Mn 152.94 Mn 1.95 Mn -7.39 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.39 Mn
Sep 30, 2025 -7.92 Mn
Jun 30, 2025 -4.63 Mn
Dec 31, 2024 -4.64 Mn
Sep 30, 2024 -5.79 Mn
Jun 30, 2024 -5.27 Mn